Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Benign prostatic hyperplasia (BPH) also known as benign prostatic hypertrophy is characterized by the unusual propagation of the prostatic cells, which causes difficulties like urinary retention and infections of the urinary tract. It is most common among the aging men population, primarily driving this market. On the basis of geographical analysis, the North American region is expected to retain its dominance in this market owing to better healthcare infrastructure, high healthcare expenditure on urological disorders, increased awareness in the society increasing the outpatients center and hospitals visits.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Benign Prostatic Hyperplasia market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Benign Prostatic Hyperplasia market. Detailed analysis of key players, along with key growth strategies adopted by Benign Prostatic Hyperplasia industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Abbott
Allergan
Pfizer
Mylan
Novartis
Sanofi
Eli Lilly
TEVA
Merck
GlaxoSmithKline
Astellas Pharma
By Type:
Drug Therapy
Dialysis
Other
By End-User:
Hospitals
Clinics
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Benign Prostatic Hyperplasia Market
-
1.3 Market Segment by Type
-
1.3.1 China Benign Prostatic Hyperplasia Market Size and Growth Rate of Drug Therapy from 2016 to 2027
-
1.3.2 China Benign Prostatic Hyperplasia Market Size and Growth Rate of Dialysis from 2016 to 2027
-
1.3.3 China Benign Prostatic Hyperplasia Market Size and Growth Rate of Other from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Benign Prostatic Hyperplasia Market Size and Growth Rate of Hospitals from 2016 to 2027
-
1.4.2 China Benign Prostatic Hyperplasia Market Size and Growth Rate of Clinics from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Benign Prostatic Hyperplasia Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Benign Prostatic Hyperplasia Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Benign Prostatic Hyperplasia Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Benign Prostatic Hyperplasia Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Benign Prostatic Hyperplasia Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Benign Prostatic Hyperplasia Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Benign Prostatic Hyperplasia Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Benign Prostatic Hyperplasia Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Benign Prostatic Hyperplasia by Major Types
-
3.4.1 Market Size and Growth Rate of Drug Therapy
-
3.4.2 Market Size and Growth Rate of Dialysis
-
3.4.3 Market Size and Growth Rate of Other
4 Segmentation of Benign Prostatic Hyperplasia Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Benign Prostatic Hyperplasia by Major End-Users
-
4.4.1 Market Size and Growth Rate of Benign Prostatic Hyperplasia in Hospitals
-
4.4.2 Market Size and Growth Rate of Benign Prostatic Hyperplasia in Clinics
5 Market Analysis by Regions
-
5.1 China Benign Prostatic Hyperplasia Production Analysis by Regions
-
5.2 China Benign Prostatic Hyperplasia Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Benign Prostatic Hyperplasia Landscape Analysis
-
6.1 North China Benign Prostatic Hyperplasia Landscape Analysis by Major Types
-
6.2 North China Benign Prostatic Hyperplasia Landscape Analysis by Major End-Users
7 Central China Benign Prostatic Hyperplasia Landscape Analysis
-
7.1 Central China Benign Prostatic Hyperplasia Landscape Analysis by Major Types
-
7.2 Central China Benign Prostatic Hyperplasia Landscape Analysis by Major End-Users
8 South China Benign Prostatic Hyperplasia Landscape Analysis
-
8.1 South China Benign Prostatic Hyperplasia Landscape Analysis by Major Types
-
8.2 South China Benign Prostatic Hyperplasia Landscape Analysis by Major End-Users
9 East China Benign Prostatic Hyperplasia Landscape Analysis
-
9.1 East China Benign Prostatic Hyperplasia Landscape Analysis by Major Types
-
9.2 East China Benign Prostatic Hyperplasia Landscape Analysis by Major End-Users
10 Northeast China Benign Prostatic Hyperplasia Landscape Analysis
-
10.1 Northeast China Benign Prostatic Hyperplasia Landscape Analysis by Major Types
-
10.2 Northeast China Benign Prostatic Hyperplasia Landscape Analysis by Major End-Users
11 Southwest China Benign Prostatic Hyperplasia Landscape Analysis
-
11.1 Southwest China Benign Prostatic Hyperplasia Landscape Analysis by Major Types
-
11.2 Southwest China Benign Prostatic Hyperplasia Landscape Analysis by Major End-Users
12 Northwest China Benign Prostatic Hyperplasia Landscape Analysis
-
12.1 Northwest China Benign Prostatic Hyperplasia Landscape Analysis by Major Types
-
12.2 Northwest China Benign Prostatic Hyperplasia Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Abbott
-
13.1.1 Abbott Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Allergan
-
13.2.1 Allergan Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Pfizer
-
13.3.1 Pfizer Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Mylan
-
13.4.1 Mylan Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Novartis
-
13.5.1 Novartis Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Sanofi
-
13.6.1 Sanofi Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Eli Lilly
-
13.7.1 Eli Lilly Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 TEVA
-
13.8.1 TEVA Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Merck
-
13.9.1 Merck Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 GlaxoSmithKline
-
13.10.1 GlaxoSmithKline Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
-
13.11 Astellas Pharma
-
13.11.1 Astellas Pharma Company Profile and Recent Development
-
13.11.2 Market Performance
-
13.11.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Benign Prostatic Hyperplasia Market Size and Growth Rate of Drug Therapy from 2016 to 2027
-
Figure China Benign Prostatic Hyperplasia Market Size and Growth Rate of Dialysis from 2016 to 2027
-
Figure China Benign Prostatic Hyperplasia Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Benign Prostatic Hyperplasia Market Size and Growth Rate of Hospitals from 2016 to 2027
-
Figure China Benign Prostatic Hyperplasia Market Size and Growth Rate of Clinics from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Benign Prostatic Hyperplasia Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Benign Prostatic Hyperplasia Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Benign Prostatic Hyperplasia Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Benign Prostatic Hyperplasia Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Benign Prostatic Hyperplasia Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Benign Prostatic Hyperplasia Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Benign Prostatic Hyperplasia Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Benign Prostatic Hyperplasia Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Benign Prostatic Hyperplasia
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Benign Prostatic Hyperplasia by Different Types from 2016 to 2027
-
Table Consumption Share of Benign Prostatic Hyperplasia by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Drug Therapy
-
Figure Market Size and Growth Rate of Dialysis
-
Figure Market Size and Growth Rate of Other
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Benign Prostatic Hyperplasia by Different End-Users from 2016 to 2027
-
Table Consumption Share of Benign Prostatic Hyperplasia by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospitals
-
Figure Market Size and Growth Rate of Clinics
-
Table China Benign Prostatic Hyperplasia Production by Regions
-
Table China Benign Prostatic Hyperplasia Production Share by Regions
-
Figure China Benign Prostatic Hyperplasia Production Share by Regions in 2016
-
Figure China Benign Prostatic Hyperplasia Production Share by Regions in 2021
-
Figure China Benign Prostatic Hyperplasia Production Share by Regions in 2027
-
Table China Benign Prostatic Hyperplasia Consumption by Regions
-
Table China Benign Prostatic Hyperplasia Consumption Share by Regions
-
Figure China Benign Prostatic Hyperplasia Consumption Share by Regions in 2016
-
Figure China Benign Prostatic Hyperplasia Consumption Share by Regions in 2021
-
Figure China Benign Prostatic Hyperplasia Consumption Share by Regions in 2027
-
Table North China Benign Prostatic Hyperplasia Consumption by Types from 2016 to 2027
-
Table North China Benign Prostatic Hyperplasia Consumption Share by Types from 2016 to 2027
-
Figure North China Benign Prostatic Hyperplasia Consumption Share by Types in 2016
-
Figure North China Benign Prostatic Hyperplasia Consumption Share by Types in 2021
-
Figure North China Benign Prostatic Hyperplasia Consumption Share by Types in 2027
-
Table North China Benign Prostatic Hyperplasia Consumption by End-Users from 2016 to 2027
-
Table North China Benign Prostatic Hyperplasia Consumption Share by End-Users from 2016 to 2027
-
Figure North China Benign Prostatic Hyperplasia Consumption Share by End-Users in 2016
-
Figure North China Benign Prostatic Hyperplasia Consumption Share by End-Users in 2021
-
Figure North China Benign Prostatic Hyperplasia Consumption Share by End-Users in 2027
-
Table Central China Benign Prostatic Hyperplasia Consumption by Types from 2016 to 2027
-
Table Central China Benign Prostatic Hyperplasia Consumption Share by Types from 2016 to 2027
-
Figure Central China Benign Prostatic Hyperplasia Consumption Share by Types in 2016
-
Figure Central China Benign Prostatic Hyperplasia Consumption Share by Types in 2021
-
Figure Central China Benign Prostatic Hyperplasia Consumption Share by Types in 2027
-
Table Central China Benign Prostatic Hyperplasia Consumption by End-Users from 2016 to 2027
-
Table Central China Benign Prostatic Hyperplasia Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Benign Prostatic Hyperplasia Consumption Share by End-Users in 2016
-
Figure Central China Benign Prostatic Hyperplasia Consumption Share by End-Users in 2021
-
Figure Central China Benign Prostatic Hyperplasia Consumption Share by End-Users in 2027
-
Table South China Benign Prostatic Hyperplasia Consumption by Types from 2016 to 2027
-
Table South China Benign Prostatic Hyperplasia Consumption Share by Types from 2016 to 2027
-
Figure South China Benign Prostatic Hyperplasia Consumption Share by Types in 2016
-
Figure South China Benign Prostatic Hyperplasia Consumption Share by Types in 2021
-
Figure South China Benign Prostatic Hyperplasia Consumption Share by Types in 2027
-
Table South China Benign Prostatic Hyperplasia Consumption by End-Users from 2016 to 2027
-
Table South China Benign Prostatic Hyperplasia Consumption Share by End-Users from 2016 to 2027
-
Figure South China Benign Prostatic Hyperplasia Consumption Share by End-Users in 2016
-
Figure South China Benign Prostatic Hyperplasia Consumption Share by End-Users in 2021
-
Figure South China Benign Prostatic Hyperplasia Consumption Share by End-Users in 2027
-
Table East China Benign Prostatic Hyperplasia Consumption by Types from 2016 to 2027
-
Table East China Benign Prostatic Hyperplasia Consumption Share by Types from 2016 to 2027
-
Figure East China Benign Prostatic Hyperplasia Consumption Share by Types in 2016
-
Figure East China Benign Prostatic Hyperplasia Consumption Share by Types in 2021
-
Figure East China Benign Prostatic Hyperplasia Consumption Share by Types in 2027
-
Table East China Benign Prostatic Hyperplasia Consumption by End-Users from 2016 to 2027
-
Table East China Benign Prostatic Hyperplasia Consumption Share by End-Users from 2016 to 2027
-
Figure East China Benign Prostatic Hyperplasia Consumption Share by End-Users in 2016
-
Figure East China Benign Prostatic Hyperplasia Consumption Share by End-Users in 2021
-
Figure East China Benign Prostatic Hyperplasia Consumption Share by End-Users in 2027
-
Table Northeast China Benign Prostatic Hyperplasia Consumption by Types from 2016 to 2027
-
Table Northeast China Benign Prostatic Hyperplasia Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Benign Prostatic Hyperplasia Consumption Share by Types in 2016
-
Figure Northeast China Benign Prostatic Hyperplasia Consumption Share by Types in 2021
-
Figure Northeast China Benign Prostatic Hyperplasia Consumption Share by Types in 2027
-
Table Northeast China Benign Prostatic Hyperplasia Consumption by End-Users from 2016 to 2027
-
Table Northeast China Benign Prostatic Hyperplasia Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Benign Prostatic Hyperplasia Consumption Share by End-Users in 2016
-
Figure Northeast China Benign Prostatic Hyperplasia Consumption Share by End-Users in 2021
-
Figure Northeast China Benign Prostatic Hyperplasia Consumption Share by End-Users in 2027
-
Table Southwest China Benign Prostatic Hyperplasia Consumption by Types from 2016 to 2027
-
Table Southwest China Benign Prostatic Hyperplasia Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Benign Prostatic Hyperplasia Consumption Share by Types in 2016
-
Figure Southwest China Benign Prostatic Hyperplasia Consumption Share by Types in 2021
-
Figure Southwest China Benign Prostatic Hyperplasia Consumption Share by Types in 2027
-
Table Southwest China Benign Prostatic Hyperplasia Consumption by End-Users from 2016 to 2027
-
Table Southwest China Benign Prostatic Hyperplasia Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Benign Prostatic Hyperplasia Consumption Share by End-Users in 2016
-
Figure Southwest China Benign Prostatic Hyperplasia Consumption Share by End-Users in 2021
-
Figure Southwest China Benign Prostatic Hyperplasia Consumption Share by End-Users in 2027
-
Table Northwest China Benign Prostatic Hyperplasia Consumption by Types from 2016 to 2027
-
Table Northwest China Benign Prostatic Hyperplasia Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Benign Prostatic Hyperplasia Consumption Share by Types in 2016
-
Figure Northwest China Benign Prostatic Hyperplasia Consumption Share by Types in 2021
-
Figure Northwest China Benign Prostatic Hyperplasia Consumption Share by Types in 2027
-
Table Northwest China Benign Prostatic Hyperplasia Consumption by End-Users from 2016 to 2027
-
Table Northwest China Benign Prostatic Hyperplasia Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Benign Prostatic Hyperplasia Consumption Share by End-Users in 2016
-
Figure Northwest China Benign Prostatic Hyperplasia Consumption Share by End-Users in 2021
-
Figure Northwest China Benign Prostatic Hyperplasia Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Abbott
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott
-
Figure Sales and Growth Rate Analysis of Abbott
-
Figure Revenue and Market Share Analysis of Abbott
-
Table Product and Service Introduction of Abbott
-
Table Company Profile and Development Status of Allergan
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan
-
Figure Sales and Growth Rate Analysis of Allergan
-
Figure Revenue and Market Share Analysis of Allergan
-
Table Product and Service Introduction of Allergan
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Mylan
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan
-
Figure Sales and Growth Rate Analysis of Mylan
-
Figure Revenue and Market Share Analysis of Mylan
-
Table Product and Service Introduction of Mylan
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
Table Company Profile and Development Status of Eli Lilly
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly
-
Figure Sales and Growth Rate Analysis of Eli Lilly
-
Figure Revenue and Market Share Analysis of Eli Lilly
-
Table Product and Service Introduction of Eli Lilly
-
Table Company Profile and Development Status of TEVA
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of TEVA
-
Figure Sales and Growth Rate Analysis of TEVA
-
Figure Revenue and Market Share Analysis of TEVA
-
Table Product and Service Introduction of TEVA
-
Table Company Profile and Development Status of Merck
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck
-
Figure Sales and Growth Rate Analysis of Merck
-
Figure Revenue and Market Share Analysis of Merck
-
Table Product and Service Introduction of Merck
-
Table Company Profile and Development Status of GlaxoSmithKline
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline
-
Table Product and Service Introduction of GlaxoSmithKline
-
Table Company Profile and Development Status of Astellas Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma
-
Figure Sales and Growth Rate Analysis of Astellas Pharma
-
Figure Revenue and Market Share Analysis of Astellas Pharma
-
Table Product and Service Introduction of Astellas Pharma
-
